2022
DOI: 10.3390/ijms23115954
|View full text |Cite
|
Sign up to set email alerts
|

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System

Abstract: Neurotransmitters are molecules that amplify, transmit, and convert signals in cells, having an essential role in information transmission throughout the nervous system. Hundreds of such chemicals have been discovered in the last century, continuing to be identified and studied concerning their action on brain health. These substances have been observed to influence numerous functions, including emotions, thoughts, memories, learning, and movements. Thus, disturbances in neurotransmitters’ homeostasis started … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
43
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 93 publications
(50 citation statements)
references
References 175 publications
0
43
0
Order By: Relevance
“…Other biochemical alterations responsible for neurodegeneration include abnormal protein folding, mitochondrial dysfunctions, and neuroinflammation [ 3 ]. Moreover, neurotransmitter disturbances are one of the essential dysfunctions observed in Alzheimer’s and non-Alzheimer’s dementias [ 4 ]. Nevertheless, the pathogenesis of AD is not fully understood and there is still no cure or even a fully functional treatment to slow the progression of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Other biochemical alterations responsible for neurodegeneration include abnormal protein folding, mitochondrial dysfunctions, and neuroinflammation [ 3 ]. Moreover, neurotransmitter disturbances are one of the essential dysfunctions observed in Alzheimer’s and non-Alzheimer’s dementias [ 4 ]. Nevertheless, the pathogenesis of AD is not fully understood and there is still no cure or even a fully functional treatment to slow the progression of the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Our analysis also identified non-selective dopamine agonists (Bromocriptine mesylate and Cabergoline) and serotonin modulators (Mirtazapine, Asenapine maleate, Sumatriptan succinate) which showed a CsA-like behavioral profile. Dopamine and serotonin receptors are GPCRs, similar to other targets described previously, known to act on various downstream signaling pathways resulting in differential transcription of certain genes 54 . A variety of other drug targets identified in the current study are known to act on various other receptors (estrogen, vesicular monoamine transporters, kainate, androgen, Pregnane X, VEGFR, EGFR, Calcium channels) and enzymes (cyclooxygenase, Raf Kinase, www.nature.com/scientificreports/ Src Kinase, Phosphodiesterases, and Histone demethylases).…”
Section: Discussionmentioning
confidence: 81%
“…The diverse downstream pathways activated by the adrenergic system and the fine balance between these are crucial. In cases where too little or too much signaling occurs, can result in the rapid pathological progression of AD and other neurological diseases 54 . Changes in the adrenergic system are an important early hallmark in the progression of AD 55 .…”
Section: Discussionmentioning
confidence: 99%
“…GABA lowers heart rate and blood pressure which helps the brain to relax and fall asleep [21]. Dopamine is known as the brain"s reward system and regulates voluntary movement [22]. Serotonin (5-HT) plays important role in controlling the central nervous system (CNS) and the peripheral nervous system (PNS).…”
Section: Discussionmentioning
confidence: 99%